
    
      The purpose of this study is evaluate the efficay and safety of benzonatate soft capsules for
      improving adult cough symtoms. The study was designed to be randomized, double-blind,
      placebo-controlled.Subjects were randomly assigned to the benzonatate soft capsule group and
      the placebo group on a 1:1 basisã€‚According to the regulatory requirements, 200 cases were
      planned to be included. Considering that poor efficacy of the placebo control group might
      lead to shedding, a 10% increase in shedding was achieved, and 220 cases were finally
      determined, with 110 cases in each group.
    
  